NEUROPSYCHOLOGICAL TEST BATTERY
The purpose of this ongoing study is to test the utility of a set of tests of thinking and memory in detecting change over time in persons with Alzheimer's disease. This study is currently recruiting normal control subjects ages 50-85. There is no medication adminstered in this study. Subjects are compensated $250 per visit in this 18 month study. For more information., please call the Kagan Treatment Development Program at (310) 794-6191.

METABOLIC CEREBRAL IMAGING IN INCIPIENT DEMENTIA (MCI-ID)
Participants (age 55 or older and not receiving treatment for any dementia-related disorder) are sought who are experiencing problems with memory, communication skills, or general mental state. These changes could be the result of normal aging, or they could be early warnings of developing Alzheimer's disease. Through this study, we aim to determine whether data on brain metabolism can affect diagnosis and management decisions and lead to improved clinical outcomes of patients who get PET scans at an early stage of mental decline.

For more information, contact Dan Silverman by email (dsilver@ucla.edu) or through the UCLA Page Operator (310-825-6301, push "1" when you hear a recording to bypass the phone tree, and ask for "Dr. Daniel Silverman" to be paged to the number which you'd like him to call back.)